METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS

This adverse event was reported 254 times

These drugs are most commonly taken by patients reporting METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS:

# Drug Count
0 RESMETIROM 68
1 ORAL SEMAGLUTIDE 32
2 METFORMIN 31
3 ASPIRIN 21
4 ASPIRIN 325 MG 21
5 ASPIRIN 81 MG 21
6 METFORMIN ER 500 MG 21
7 METFORMIN ER 750 MG 21
8 PREDNISONE 21
9 ALBUTEROL SULFATE 18
See all common drugs associated with METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS

METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RESMETIROM 68 0.0296
1 INFLIXIMAB-AXXQ 2 0.0017
2 INFLIXIMAB-DYYB 4 0.0012
3 BELATACEPT 5 0.0011
4 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 2 0.0009
5 CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES 5 0.0005
6 ERGOCALCIFEROL 16 0.0005
7 ORAL SEMAGLUTIDE 32 0.0004
8 RIFAXIMIN 8 0.0004
9 ICOSAPENT ETHYL 2 0.0002
See all drugs enriched for association with METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS